4//SEC Filing
Ehrlich Christopher B 4
Accession 0001213900-25-050116
CIK 0001870404other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:04 PM ET
Size
13.1 KB
Accession
0001213900-25-050116
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+61,843→ 61,842 totalExercise: $0.45Exp: 2035-05-29→ Common Stock (61,842 underlying)
Footnotes (1)
- [F1]Represents the 1/3 time-based portion of an award of options to purchase 185,529 shares, vesting in equal monthly installments on the 4th of each month from July 4, 2025 through December 4, 2025, with the remaining portion subject to performance conditions.
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:04 PM ET
- Size
- 13.1 KB